8-K: Chicago Atlantic Real Estate Finance Q1 2026 Results

Chicago Atlantic Real Estate Finance announced stable Q1 2026 results, navigating macro instability with a differentiated loan portfolio and benefiting from cannabis industry policy shifts.

Summary

• Chicago Atlantic Real Estate Finance (REFI) reported stable financial results for the first quarter ended March 31, 2026, amidst a challenging macro environment.
• The company's strategy of sourcing shorter-duration loans with profitable, diversified operators has insulated its portfolio from broader private credit market pressures.
• All loans are protected by fixed rates or floating rates with floors at or above the Prime rate, contributing to a consistent weighted average portfolio yield.
• The rescheduling of medical cannabis from Schedule I to Schedule III by the federal government is viewed as a significant positive development, expected to strengthen operator balance sheets and improve borrower credit profiles.
• Total loan principal outstanding increased slightly to $413.6 million from $411.1 million in the prior quarter, with a decrease in the number of portfolio companies from 26 to 25.
• Net interest income for the quarter was $13.1 million, a slight increase from $13.0 million in the same period last year.
• Net income was $4.8 million ($0.23 per basic share), down from $10.0 million ($0.48 per basic share) in Q1 2025, largely due to a provision for expected credit losses of $3.8 million.
• Distributable earnings were $9.8 million ($0.46 per diluted share), compared to $9.7 million ($0.46 per diluted share) in Q1 2025.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing. While net income declined due to credit loss provisions, core distributable earnings remained stable, and the company is well-positioned to benefit from positive regulatory changes in the cannabis industry.

Positives

• Stable results achieved in a challenging macro environment through a differentiated lending strategy.
• Portfolio protected by fixed rates or floating rates with floors at or above Prime, ensuring consistent yield.
• Significant positive impact expected from the federal rescheduling of medical cannabis, potentially improving operator financials and credit profiles.
• Total loan principal outstanding increased to $413.6 million, indicating continued investment activity.
• Gross unlevered weighted average yield to maturity remained strong at 15.8%.

Negatives

• Net income decreased significantly to $4.8 million in Q1 2026 from $10.0 million in Q1 2025.
• A substantial provision for current expected credit losses of $3.8 million was recorded in Q1 2026, compared to a benefit of $1.1 million in Q1 2025.
• Book value per share decreased to $14.39 from $14.87 in the prior year.
• Debt/equity ratio increased to 38.4% from 28.0% in the prior year.

Risks

• The company acknowledges that new risks and uncertainties arise over time and it is not possible to predict them or their impact.
• Factors that may cause actual results to differ materially from current expectations include global conflicts, market volatility, the ability of the Manager to locate and manage loan opportunities, government actions and policies (including the federal illegality of cannabis), evolving cannabis market dynamics, economic trends, cash flow timing, financing availability, changes in loan values, underwriting processes, default rates, hedging strategies, interest rate changes, inflation, departure of key personnel, changes in regulations and tax law, and the company's ability to maintain its REIT status and exclusion from the Investment Company Act of 1940.
• The cannabis industry remains illegal under federal law, despite recent rescheduling efforts.
• The company's business is concentrated in the cannabis industry, which is subject to significant regulatory and legal risks.

Future Outlook

The Company expects to maintain a dividend payout ratio based on Distributable Earnings per weighted average diluted share of approximately 90% to 100% on a full year basis for 2026. If taxable income requires additional distribution beyond the regular quarterly dividend, the Company expects to meet this requirement with a special dividend in the fourth quarter of 2026.

Management Comments

• Chicago Atlantic delivered stable results for the first quarter of 2026 in an unstable macro environment by continuing to differentiate ourselves from other capital providers.
• Sourcing loans with shorter durations that are not broadly marketed and backed by operators and facilities that are profitable and diversified across geographies and distribution channels has kept our portfolio relatively insulated from the current pressures impacting the broader private credit markets.
• With 100% of our loans protected by either fixed rates or floating rates with floors at or above the Prime rate, we have been able to generate a consistent weighted average portfolio yield.
• We remain encouraged by opportunities for the cannabis industry, and the rescheduling of medical cannabis from Schedule I to Schedule III by an order of the Federal government last month marks the most significant federal policy for the industry in its history.
• We expect this order, when implemented, to strengthen operator balance sheets and improve cash flows which would improve the credit profiles of our borrowers.
• We look forward to the establishment of a framework in upcoming months for the new policy.

Industry Context

StockSavvy.ai notes that Chicago Atlantic's focus on the cannabis industry, while niche, is strategically positioned to benefit from evolving federal and state regulations. The recent rescheduling of medical cannabis to Schedule III is a significant development that could unlock substantial capital and improve creditworthiness for operators, directly benefiting lenders like Chicago Atlantic. The company's emphasis on shorter-duration loans and robust collateral coverage appears to be a prudent strategy in navigating the inherent volatility of this sector.

Comparison to Industry Standards

• The company's gross unlevered weighted average yield to maturity of 15.8% is notably high compared to traditional commercial real estate debt, reflecting the higher risk and specialized nature of cannabis lending.
• The 1.2x real estate collateral coverage ratio is a strong indicator of conservative underwriting, providing a buffer against potential defaults.
• The 43.7% weighted average loan-to-enterprise value ratio also suggests a prudent approach to leverage, offering protection to lenders.
• Compared to broader REITs, Chicago Atlantic's debt/equity ratio of 38.4% is moderate, but has increased from 28.0% in the prior year, warranting monitoring.

Related Party Transactions

• Loans held for investment - related party: $76,775,335 as of March 31, 2026.
• Related party payables: $1,453,942 as of March 31, 2026.
• Related party receivables: $65,776 as of March 31, 2026.

Stakeholder Impact

• Shareholders: The company aims to provide consistent dividends, with a target payout ratio of 90-100% of distributable earnings. The recent provision for credit losses impacted net income, but distributable earnings remained stable.
• Borrowers: The rescheduling of cannabis to Schedule III is expected to improve operator balance sheets and credit profiles, potentially leading to better access to capital and more favorable terms.
• Creditors: The company's debt/equity ratio increased, which may be a point of consideration for creditors, though collateral coverage remains strong.

Next Steps

• The company will continue to monitor the implementation of the new cannabis policy framework.
• The company expects to meet any additional taxable income distribution requirements for 2026 with a special dividend in Q4 2026.
• The company will host a conference call and live audio webcast to discuss its Q1 2026 financial results.

Key Dates

Recommendation

The company demonstrates resilience in a challenging market with stable distributable earnings and a strong yield. The potential benefits from cannabis industry regulatory changes are significant. However, the decrease in net income due to credit loss provisions and the increase in the debt/equity ratio warrant a cautious 'hold' rating pending further clarity on credit performance and the full impact of regulatory shifts.

Keywords

Chicago Atlantic Real Estate Finance, REFI, Cannabis Lending, Commercial Mortgage REIT, Q1 2026 Earnings, Financial Results, Real Estate Investment Trust, SEC Filing